There are 2 article(s) tagged Mitchell Steiner:

• May 2022

  • Memphis-connected COVID drug fast-tracked for emergency use

    The drug was created as an anti-cancer agent in collaboration with GTx, a former Memphis pharmaceutical firm.

    By Jane Roberts May 13, 2022

• April 2022

  • Memphis scientists instrumental in new, landmark COVID drug

    The next possible landmark COVID drug is so rich in Memphis DNA that if approved by the FDA, patent royalty checks will immediately flow to town. Plus, it’s in capsule form, taken once a day for 21 days. It does not need to be refrigerated and can be shipped easily and inexpensively around the world.

    By Jane Roberts April 21, 2022